2002•Biochemical PharmacologyRequires access

Reduced (±)-3,4-methylenedioxymethamphetamine (“Ecstasy”) metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro

Yamini Ramamoorthy, Ai‐Ming Yu, Nina Suh, Robert L. Haining, Rachel F. Tyndale, Edward M. Sellers

Open publisher page 66 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 66 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: MDMA, CYP2D6, Dextromethorphan, Ecstasy, Pharmacology, CYP2B6, Cytochrome P450, Chemistry

Back to paper search Browse research topics Original source

Reduced (±)-3,4-methylenedioxymethamphetamine (“Ecstasy”) metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro — Research Paper | ScholarLens